Presentation by Daniel Raymond, the Harm Reduction Coalition's Policy Director, to the Institute of Medicine's Committee on Prevention and Control of Viral Hepatitis Infections on March 3, 2009.
Hepatitis B & C - the Basics for Primary CareJarrod Lee
This presentation covers the basics in Hepatitis B & C, and is aimed at primary care physicians who may encounter such patients. It focuses mainly on the natural history, how to diagnose and monitor the disease, and when to refer to a specialist.
Other SEP Activities - 17th Texas HIV/STD ConferenceDan Bigg
Implications of Lifting the Federal Funding Ban on Syringe Exchange at Texas HIV/STD Conference. Powerpoint by Dan Bigg, Chicago Recovery Alliance. Please use with credit to Chicago Recovery Alliance. Dan @ cra@attglobal.net or anypositivechange.org
lecture submitted to healthcare workers ( physicians,dentists,nurses,lab.technicians) to explain the best methods to avoid transmission of hepatitis through health practices
The views expressed in the presentations are that of the author and do not necessarily reflect the views of the Government of Canada. Presentations are shared in the original format received from the presenter.
Presentations given at the Conference to Develop a Federal Framework on Lyme Disease are the property of the author, unless otherwise cited. If you reference the author's work, you must give the author credit by naming the author and their work as well as the place and date it was presented.
For more information, contact the Lyme Disease Conference Secretariat at maladie_lyme_disease@phac-aspc.gc.ca
Hepatitis B & C - the Basics for Primary CareJarrod Lee
This presentation covers the basics in Hepatitis B & C, and is aimed at primary care physicians who may encounter such patients. It focuses mainly on the natural history, how to diagnose and monitor the disease, and when to refer to a specialist.
Other SEP Activities - 17th Texas HIV/STD ConferenceDan Bigg
Implications of Lifting the Federal Funding Ban on Syringe Exchange at Texas HIV/STD Conference. Powerpoint by Dan Bigg, Chicago Recovery Alliance. Please use with credit to Chicago Recovery Alliance. Dan @ cra@attglobal.net or anypositivechange.org
lecture submitted to healthcare workers ( physicians,dentists,nurses,lab.technicians) to explain the best methods to avoid transmission of hepatitis through health practices
The views expressed in the presentations are that of the author and do not necessarily reflect the views of the Government of Canada. Presentations are shared in the original format received from the presenter.
Presentations given at the Conference to Develop a Federal Framework on Lyme Disease are the property of the author, unless otherwise cited. If you reference the author's work, you must give the author credit by naming the author and their work as well as the place and date it was presented.
For more information, contact the Lyme Disease Conference Secretariat at maladie_lyme_disease@phac-aspc.gc.ca
Gabriel Wagner, MD
Associate Clinical Professor
Division of Infectious Diseases & Global Public Health
Department of Medicine
University of California, San Diego
What the new hepatitis C protease inhibitors Incivek and Victrelis mean for people coinfected with HIV & HCV and for health departments. Presented at the NASTAD annual meeting 5/23/11.
Survillance and notification of communicable diseasemubeenButt5
Ongoing, systematic collection, analysis and interpretation of health data.
Surveillance and notification of communicable disease
1-Closely integrated with the timely dissemination to those who need to know.
Application of the data to preventing and controlling disease.
2-Authoritative or urgent, formal or legal notice.
The action of notifying someone or something.
Something that gives official information to someone : the act of notifying someone.
3-Monitor closely to all patients.
Collect patient’s data for clinical decision making.
Monitor different diagnostic tests and lab investigations if needed.
Implement interventions on patients and evaluate for the outcomes.
To conduct researches nurse can collect data.
To assess status of community and identify problems.
To detect changes in health care practices .
Administration of general and specific health survey.
Participation in early diagnosis and treatment
Identification and notification of certain specific diseases.
Health education.
5-Crude birth rate
Crude death rate
Infant mortality rate
Morbidity rate
Perinatal mortality rate
Maternal mortality rate
Life expectancy
General fertility rate
Best Practices in the Management of HCV/HIV Coinfection: Optimizing Treatment...Hivlife Info
Jürgen K. Rockstroh, MD, provides an update on the importance of HCV screening and the latest emerging treatment options for patients with HCV/HIV coinfection.
The views expressed in the presentations are that of the author and do not necessarily reflect the views of the Government of Canada. Presentations are shared in the original format received from the presenter.
Presentations given at the Conference to Develop a Federal Framework on Lyme Disease are the property of the author, unless otherwise cited. If you reference the author's work, you must give the author credit by naming the author and their work as well as the place and date it was presented.
For more information, contact the Lyme Disease Conference Secretariat at maladie_lyme_disease@phac-aspc.gc.ca
Gabriel Wagner, MD
Assistant Professor of Medicine
Division of Infectious Diseases & Global Public Health
Department of Medicine
University of California, San Diego
The views expressed in the presentations are that of the author and do not necessarily reflect the views of the Government of Canada. Presentations are shared in the original format received from the presenter.
Presentations given at the Conference to Develop a Federal Framework on Lyme Disease are the property of the author, unless otherwise cited. If you reference the author's work, you must give the author credit by naming the author and their work as well as the place and date it was presented.
For more information, contact the Lyme Disease Conference Secretariat at maladie_lyme_disease@phac-aspc.gc.ca
The views expressed in the presentations are that of the author and do not necessarily reflect the views of the Government of Canada. Presentations are shared in the original format received from the presenter.
Presentations given at the Conference to Develop a Federal Framework on Lyme Disease are the property of the author, unless otherwise cited. If you reference the author's work, you must give the author credit by naming the author and their work as well as the place and date it was presented.
For more information, contact the Lyme Disease Conference Secretariat at maladie_lyme_disease@phac-aspc.gc.ca
Gabriel Wagner, MD
Associate Clinical Professor
Division of Infectious Diseases & Global Public Health
Department of Medicine
University of California, San Diego
What the new hepatitis C protease inhibitors Incivek and Victrelis mean for people coinfected with HIV & HCV and for health departments. Presented at the NASTAD annual meeting 5/23/11.
Survillance and notification of communicable diseasemubeenButt5
Ongoing, systematic collection, analysis and interpretation of health data.
Surveillance and notification of communicable disease
1-Closely integrated with the timely dissemination to those who need to know.
Application of the data to preventing and controlling disease.
2-Authoritative or urgent, formal or legal notice.
The action of notifying someone or something.
Something that gives official information to someone : the act of notifying someone.
3-Monitor closely to all patients.
Collect patient’s data for clinical decision making.
Monitor different diagnostic tests and lab investigations if needed.
Implement interventions on patients and evaluate for the outcomes.
To conduct researches nurse can collect data.
To assess status of community and identify problems.
To detect changes in health care practices .
Administration of general and specific health survey.
Participation in early diagnosis and treatment
Identification and notification of certain specific diseases.
Health education.
5-Crude birth rate
Crude death rate
Infant mortality rate
Morbidity rate
Perinatal mortality rate
Maternal mortality rate
Life expectancy
General fertility rate
Best Practices in the Management of HCV/HIV Coinfection: Optimizing Treatment...Hivlife Info
Jürgen K. Rockstroh, MD, provides an update on the importance of HCV screening and the latest emerging treatment options for patients with HCV/HIV coinfection.
The views expressed in the presentations are that of the author and do not necessarily reflect the views of the Government of Canada. Presentations are shared in the original format received from the presenter.
Presentations given at the Conference to Develop a Federal Framework on Lyme Disease are the property of the author, unless otherwise cited. If you reference the author's work, you must give the author credit by naming the author and their work as well as the place and date it was presented.
For more information, contact the Lyme Disease Conference Secretariat at maladie_lyme_disease@phac-aspc.gc.ca
Gabriel Wagner, MD
Assistant Professor of Medicine
Division of Infectious Diseases & Global Public Health
Department of Medicine
University of California, San Diego
The views expressed in the presentations are that of the author and do not necessarily reflect the views of the Government of Canada. Presentations are shared in the original format received from the presenter.
Presentations given at the Conference to Develop a Federal Framework on Lyme Disease are the property of the author, unless otherwise cited. If you reference the author's work, you must give the author credit by naming the author and their work as well as the place and date it was presented.
For more information, contact the Lyme Disease Conference Secretariat at maladie_lyme_disease@phac-aspc.gc.ca
The views expressed in the presentations are that of the author and do not necessarily reflect the views of the Government of Canada. Presentations are shared in the original format received from the presenter.
Presentations given at the Conference to Develop a Federal Framework on Lyme Disease are the property of the author, unless otherwise cited. If you reference the author's work, you must give the author credit by naming the author and their work as well as the place and date it was presented.
For more information, contact the Lyme Disease Conference Secretariat at maladie_lyme_disease@phac-aspc.gc.ca
John de Wit, (NCHSR) argues that strengthening HIV prevention approaches will benefit significantly from drawing on behaviour change science. This presentation was given at the AFAO/NAPWA Gay Men's HIV Health Promotion Conference in May 2012.
Amutha Rajagopal, MD
Associate Physician Diplomate
Division of Infectious Diseases & Global Public Health
Department of Medicine
University of California, San Diego
Global Medical Cures™ | HIV TESTING IN USA
DISCLAIMER-
Global Medical Cures™ does not offer any medical advice, diagnosis, treatment or recommendations. Only your healthcare provider/physician can offer you information and recommendations for you to decide about your healthcare choices.
Running head RESEARCH PAPER1RESEARCH PAPER15.docxtodd521
Running head: RESEARCH PAPER 1
RESEARCH PAPER 15
Assessment of the knowledge, practice, and the associated factors of Healthcare Acquired Infection Prevention
Name
Institutional Affiliation
Date
Table of Contents
Table of Contents 2
Assessment of the knowledge, practice, and the associated factors of Healthcare Acquired Infection Prevention in Blessings Healthcare Facility 4
The Problem 5
Significance of the problem 6
Purpose of this study 7
Research Questions 8
Masters Essentials aligned with the topic 8
Design 10
Literature Review 10
Methodology and the design of the study 13
Sampling Methods 14
Necessary tools 14
Any logarithm or flow map developed 15
Healthcare Facility 15
Implementation 15
Stage 1: Assessment of the current practices (One Week) 16
Stage 2: Identification of the factors leading to high cases of healthcare-acquired infection (5 days) 17
Stage 3: Pre-Training (Two Weeks) 17
Stage 4: Training (5 weeks) 17
Stage 5: an ongoing process of assessing the situation 18
Materials, activities and the cost 20
Results 21
Socio-demographics features of the research population 21
Knowledge concerning the infection prevention 23
Aspects related to the knowledge of the healthcare professionals regarding the issue of preventing healthcare-acquired infections 27
Limitation of the study 28
References 30
Assessment of the knowledge, practice, and the associated factors of Healthcare Acquired Infection Prevention
Healthcare acquired infection/nosocomial infection/hospital acquired infections are becoming a major international challenge in many healthcare facilities especially in the low or middle income nations. It is anticipated that around 10 percent of patients in the healthcare facilities from developing nations are developing healthcare acquired infections and this subsequently leads to negative impacts on healthcare outcomes. It also leads to increase hospital stay, economic burden, morbidity cases, and increase in the mortality incidences. Some of the common healthcare acquired infections include Hepatitis B and C virus, HIV infections, and even Tuberculosis which are often transmitted by healthcare workers who are not observing the practice related to the infection prevention measures.
According to the United States Center for Disease Control and Prevention, there are about 1.7 million patients who have been hospitalized as a result of acquiring infection within the facilities while undergoing treatment for other healthcare concerns. Many studies reveal that simple infection control procedures like cleaning of the hands using alcohol-based hand rub is helping in the prevention of the spread of the disease. The increase in the infection rate caused by the healthcare acquired infection is due to the poor practices of infection prevention and control, lack of knowledge or failure to implement knowledge related to the process of preventing and controlling nosocomial illnesses, and other associated f.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html